News|Articles|October 6, 2025

Q3 2025 Recap: Hepatology News and Updates

Fact checked by: Ryan Livingston

The Q3 recap for hepatology spotlights key FDA news, the withdrawal of OCA for PBC, and notable hepatic research from the past few months.

The third quarter of 2025 brought a flurry of US Food and Drug Administration (FDA) news, notable changes in the primary biliary cholangitis (PBC) treatment landscape, and novel research on liver health, underscoring the rapidly evolving landscape in hepatology.